Novanta Inc. entered into a Securities Purchase Agreement on June 8, 2026, for a private placement of 2,142,857 common shares at $140.00 per share, totaling approximately $300.0 million. The company will also enter into a Registration Rights Agreement to register the resale of these shares within 30 days of the expected June 11, 2026, closing. Novanta Inc. is a provider of advanced precision technologies for medical, industrial, and life science applications.
